LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
BT-20 PIK-93
0.04
uM
LJP5
 1.0209 0.0035 1.0243 0.0044
BT-20 PIK-93
0.12
uM
LJP5
 1.0204 0.0159 1.0233 0.0176
BT-20 PIK-93
0.37
uM
LJP5
 1.0408 0.0161 1.0482 0.0198
BT-20 PIK-93
1.11
uM
LJP5
 0.9749 0.0338 0.9726 0.0391
BT-20 PIK-93
3.33
uM
LJP5
 0.7915 0.0199 0.7463 0.0190
BT-20 PIK-93
10
uM
LJP5
 0.3561 0.0016 0.0954 0.0256
BT-20 Dactolisib
0.04
uM
LJP5
 0.4495 0.0436 0.2535 0.0586
BT-20 Dactolisib
0.12
uM
LJP5
 0.3773 0.0457 0.1301 0.0663
BT-20 Dactolisib
0.37
uM
LJP5
 0.3410 0.0340 0.0662 0.0530
BT-20 Dactolisib
1.11
uM
LJP5
 0.3373 0.0088 0.0610 0.0241
BT-20 Dactolisib
3.33
uM
LJP5
 0.3339 0.0054 0.0550 0.0225
BT-20 Dactolisib
10
uM
LJP5
 0.3604 0.0051 0.1026 0.0307
BT-20 Alpelisib
0.04
uM
LJP5
 1.0369 0.0101 1.0416 0.0097
BT-20 Alpelisib
0.12
uM
LJP5
 0.9814 0.0235 0.9788 0.0276
BT-20 Alpelisib
0.37
uM
LJP5
 0.7738 0.0170 0.7221 0.0156
BT-20 Alpelisib
1.11
uM
LJP5
 0.6474 0.0576 0.5528 0.0677
BT-20 Alpelisib
3.33
uM
LJP5
 0.3717 0.0265 0.1226 0.0271
BT-20 Alpelisib
10
uM
LJP5
 0.2277 0.0178 -0.1568 0.0413
BT-20 GDC-0980
0.04
uM
LJP5
 0.5067 0.0719 0.3420 0.0991
BT-20 GDC-0980
0.12
uM
LJP5
 0.3364 0.0405 0.0572 0.0585
BT-20 GDC-0980
0.37
uM
LJP5
 0.2699 0.0220 -0.0690 0.0299
BT-20 GDC-0980
1.11
uM
LJP5
 0.2383 0.0111 -0.1333 0.0233
BT-20 GDC-0980
3.33
uM
LJP5
 0.2187 0.0074 -0.1757 0.0241
BT-20 GDC-0980
10
uM
LJP5
 0.2093 0.0068 -0.1964 0.0242
BT-20 Mitoxantrone
0.04
uM
LJP5
 0.4244 0.0400 0.2093 0.0739